I Richard Steinhart

Affiliations

  • Chief Financial Officer at Bioxcel Therapeutics Inc. (BTAI), 2024-12-17
  • at Atossa Therapeutics Inc. (ATOS), 2024-07-01
  • Director at Actinium Pharmaceuticals Inc. (ATNM), 2023-12-29
  • Chief Financial Officer at Mela Sciences Inc. (MELA), 2013-08-08
  • Director at Manhattan Pharmaceuticals Inc (MHAN), 2010-03-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BTAI $5.20 500 Officer 1,500 2018-12-03 Filing
BTAI $5.00 500 Officer 1,000 2018-11-30 Filing
BTAI $5.00 500 Officer 500 2018-11-29 Filing
ATNM $2.01 2,500 Director 2,500 2016-04-14 Filing
MELA $0.81 3,000 Officer 4,000 2013-06-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BTAI $0.36 372 Officer 20,932 2024-12-16 Filing
BTAI $0.36 205 Officer 21,157 2024-12-16 Filing
BTAI $0.55 7,175 Officer 20,279 2024-10-03 Filing
BTAI $0.69 356 Officer 6,204 2024-09-16 Filing
BTAI $1.26 372 Officer 5,476 2024-06-17 Filing